At the beginning of the Year of the Rabbit, the Arab Health 2023 was successfully held in Dubai from January 30th to February 2nd. Industry professionals from global medical device manufacturers, suppliers and distributors, medical service related institutions, industry experts, academic leaders, think tanks, and professional audiences gathered at the Dubai World Trade Center to showcase innovative products and service solutions, anticipate new trends in the industry through a collision of ideas.

As the largest medical device event in the Middle East, Arab Health has invited MicroTech Medical International team to participate four times. The team, with breakthrough medical innovation technology and one-stop glucose management solutions, came to have in-depth exchanges with friends and industry-leading technology providers from all over the world. The aim is to convey the brand value of the enterprise and enhance the international influence of the product through exchanging opinions with customers in the Middle East and Africa region.

The exhibition site is packed with people, and customers are constantly coming and going

In front of the MicroTech booth, customers from the Middle East and Africa are constantly coming, and team members bring the company's independently developed AiDEX ™ CGMS, Equil ™ Patch Insulin Pump System products. The team members not only provide customers with detailed explanations and introductions, but also allow customers to perceive the ease and convenience of the dynamic sugar measurement wearing process through on-site trial demonstrations. The enthusiastic service and guidance of the team members of MicroTech International Department have won unanimous praise from visiting customers and international partners!

Colleagues from MicroTech International Department have friendly conversations with clients

As a pioneer in glucose monitoring and management equipment in China, MicroTech Medical is the only company in the world that has been approved for the market with a patch type insulin pump and a calibration-free continuous glucose monitoring system. It is also the only comprehensive product company in China that has both continuous blood glucose monitoring and continuous subcutaneous insulin infusion products.

At present, MicroTech already had the hardware conditions to assemble its own full-automatic insulin infusion system, and has always been committed to the research of closed-loop algorithm, striving to complete the last piece of the puzzle of the automatic insulin infusion system, form its own product system into a closed-loop, and make diabetes patients around the world enjoy the convenience of life brought by technological progress as soon as possible.

The insulin pump&CGM offline training event organized by MicroTech's overseas team

In addition to providing advanced product technology and services for overseas medical institutions, MicroTech also held the first international insulin pump&CGM overseas agent training exchange conference in Dubai, attracting agent representatives from more than ten countries, including Saudi Arabia, the United Arab Emirates, Bahrain, Kuwait, Iraq, Egypt, Jordan, Algeria, Türkiye, to attend the conference.

At the meeting, Dr., the Middle East clinical consultant of the company Ayman highlighted the clinical application and value of continuous subcutaneous insulin infusion (CSII), while partners from Egypt also provided their own suggestions and insights on how to better promote the Equil Patch Insulin Pump. The atmosphere of on-site learning and communication is strong, and representatives from various countries express their recognition of MicroTech products while sharing their own experiences and gains.

From the potential of overseas markets in recent years, MicroTech's main products such as CGM, insulin pumps, and digital therapies are all in a promising blue ocean market. At the same time, with the continuous recognition and promotion of products in hospitals and clinical settings, the overall cost of products in the industry is bound to significantly decrease. The application scenarios of CGM are further expanded, allowing the entire team to have more practical thinking and prospects for future overseas market layout and returns.

The future of 2023 has come. MicroTech Medical will continue to accelerate the construction of overseas channels and markets, devote itself to helping diabetes patients have a healthier and better life, and finally realize the long-term development vision of 'benefiting global diabetes patients', becoming a universal player in China and even the world's dynamic blood glucose management.